Caroline E. Weller
Impact in
- Molecular Biology top 10%
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- Ubiquitin and proteasome pathways
- Chemical Synthesis and Analysis
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Ubiquitin and proteasome pathways 8
- Protein Degradation and Inhibitors 3
- RNA Interference and Gene Delivery 3
- Advanced biosensing and bioanalysis techniques 2
- Genomics and Chromatin Dynamics 2
- Chemical Synthesis and Analysis 2
- Oncology 5
- Peptidase Inhibition and Analysis 5
- Co-authors
- W. Mark Saltzman (5 shared papers)Champak Chatterjee (10 shared papers)Christopher J. Cheng (2 shared papers)Jie Liu (1 shared paper)Toral Patel (1 shared paper)Jiangbing Zhou (1 shared paper)Zhaozhong Jiang (1 shared paper)Joseph M. Piepmeier (1 shared paper)
- Journals
- Cancer Research (3 papers)Journal of the American Chemical Society (2 papers)ChemBioChem (2 papers)Journal of Controlled Release (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesBrazilChina
In The Last Decade
Caroline E. Weller
17 papers receiving 850 citations
Peers
Comparison fields: 5 of 73
- Molecular Biology 705
- Biomaterials 130
- Pharmaceutical Science 50
- Organic Chemistry 143
- Oncology 134
Countries citing papers authored by Caroline E. Weller
This map shows the geographic impact of Caroline E. Weller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline E. Weller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline E. Weller more than expected).
Fields of papers citing papers by Caroline E. Weller
This network shows the impact of papers produced by Caroline E. Weller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline E. Weller. The network helps show where Caroline E. Weller may publish in the future.
Co-authors
The 25 scholars most cited alongside Caroline E. Weller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 338 | |
| 2 | 2012 | 84 | |
| 3 | 2012 | 72 | |
| 4 | 2016 | 55 | |
| 5 | 2016 | 52 | |
| 6 | 2014 | 41 | |
| 7 | 2013 | 41 | |
| 8 | 2017 | 39 | |
| 9 | 2016 | 34 | |
| 10 | 2022 | 26 | |
| 11 | 2017 | 22 | |
| 12 | 2011 | 20 | |
| 13 | 2019 | 15 | |
| 14 | 2024 | 12 | |
| 15 | 2016 | 6 | |
| 16 | 2020 | 1 | |
| 17 | 2012 | 1 | |
| 18 | 2015 | 1 |
About Caroline E. Weller
Caroline E. Weller is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Genetics and Immunology, having authored 18 papers that have together received 860 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (8 papers), Peptidase Inhibition and Analysis (5 papers), Protein Degradation and Inhibitors (3 papers), Click Chemistry and Applications (3 papers), RNA Interference and Gene Delivery (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), Genomics and Chromatin Dynamics (2 papers) and Chemical Synthesis and Analysis (2 papers). The work is most often cited by research in Molecular Biology (705 citations), Biomaterials (130 citations), Pharmaceutical Science (50 citations), Organic Chemistry (143 citations) and Oncology (134 citations). Caroline E. Weller has collaborated with scholars based in United States, Brazil and China. Frequent co-authors include W. Mark Saltzman, Champak Chatterjee, Christopher J. Cheng, Jie Liu, Toral Patel, Jiangbing Zhou, Zhaozhong Jiang, Joseph M. Piepmeier, Carmen J. Booth and Jill M. Steinbach-Rankins. Their work appears in journals such as Cancer Research, Journal of the American Chemical Society, ChemBioChem, Journal of Controlled Release and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.